From: Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach
HCC patients (N = 48)
Controls (N = 33)
Age (years)
46.0 ± 11.8
41.8 ± 10.8
   Male/Female
39/9
24/9
Hepatitis B infection (%)
100% (0/48)
0% (0/33)
Hepatitis C infection (%)
0% (0/48)